FDA approves Eli Lilly’s diabetes drug Mounjaro for obesity under new name, Zepbound
By Meg Tirrell, CNN (CNN) — The US Food and Drug Administration approved the type 2 diabetes drug tirzepatide for use in chronic weight management Wednesday, making official the use of a medicine already widely prescribed off-label for weight loss. The drug, called Mounjaro for diabetes, will be called Zepbound for weight loss, according to
Continue Reading